Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer

出版年份 2015 全文链接

标题

作者

关键词

Pharmacoeconomics, Cost-effectiveness analysis, Non-small cell lung cancer, Gefitinib, Individualized medicine

出版物

Volume 90, Issue 1, Pages 71-77

出版商

Elsevier BV

发表日期

2015-07-26

DOI

10.1016/j.lungcan.2015.07.006

联系作者

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now